YOLFTbeta
Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd

036220 · KQ · Healthcare / Medical Devices

4,410.00KRW-45.00 (-1.01%)

Price History

Full chart

Market Stats

Previous Close4,455.00
Open4,520.00
Day Range4,400.00 – 4,570.00
52-Week Range5,200.00 – 14,316.72
Volume18.26K
Market Cap88.33B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.12%
Beta0.32
50-Day Avg6,603.20
200-Day Avg8,468.30

About

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Cheol-Hoon Kang
  • Employees332
  • Headquarters132, Anyangcheondong-ro, Anyang-si, South Korea, Korea
  • Websitehttps://www.osanghc.com

Leadership

  • Mr. Byungyeol YooMD & Executive Director · b. 1968
  • Mr. Cheol-Hoon KangChief Executive Officer · b. 1961
  • Sung-Dong LeeManaging Director · b. 1974

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue132.33B193.89B355.85B80.49B128.63B
Growth (%)-+46.53%+83.53%-77.38%+59.81%
Cost of Revenue84.71B95.86B134.74B54.92B71.48B
Gross Profit47.62B98.03B221.11B25.57B57.14B
Gross Margin35.98%50.56%62.14%31.77%44.43%
Operating Expense54.70B48.77B78.29B50.37B54.72B
Operating Income-7.08B49.26B142.82B-24.80B2.43B
Operating Margin-5.35%25.41%40.13%-30.82%1.89%
EBITDA-57.28B158.83B-15.87B11.50B
EBITDA Margin-29.54%44.63%-19.72%8.94%
Net Income1.46B40.65B116.44B-11.36B3.11B
Net Income Margin1.10%20.96%32.72%-14.12%2.42%
R&D9.28B12.11B16.64B20.34B19.24B
R&D as % of Total Revenue7.01%6.24%4.68%25.27%14.96%
Interest Expense15.38M25.13M58.94M27.17M1.11B
Interest Expense % of Total Revenue0.01%0.01%0.02%0.03%0.86%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets189.37B249.18B320.55B295.00B336.21B
Total Liabilities10.90B49.33B27.52B9.25B54.89B
Total Equity178.46B199.86B293.03B285.75B281.06B
Cash47.11B38.14B109.62B9.36B21.59B
Net Debt----22.32B

Cash Flow

Currency: KRW2008-12-312011-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--10.81B42.53B152.36B-38.77B6.21B
Investing Cash Flow----27.50B-55.53B-56.19B-
Financing Cash Flow----22.95B-25.23B-7.47B-
Capital Expenditure009.90B11.90B35.88B13.01B19.01B
Free Cash Flow--908.90M30.45B116.71B-51.77B-12.80B
Dividends Paid--24.53B24.90B25.35B25.17B6.86B
FCF to OCF--8.41%71.60%76.60%133.55%-205.96%
Dividend Paid to FCF--2699.31%81.75%21.72%-48.61%-53.58%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Jan 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Jun 30, 2020Sep 30, 2020Dec 31, 2020Jun 30, 2021Sep 30, 2021Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------------
EPS Actual174.00277.38-0.8336.00205.0054.89503.00101.79240.66326.7814.9275.10-31.48-654.83258.85-182.40-78.00-1089.0013.7233.03-15.13-880.90-331.22704.95140.27-1198.92-397.72-143.98135.34-582.95-98.61-11.50658.36186.15-16.23119.435.0022.9496.52-69.62-394.217043.583300.70-779.80-391.10102.561051.12440.06-484.939543.39333.47-377.08-319.29103.90-450.12-429.24-103.16286.94-17.68218.13-261.77-261.56-310.32
Surprise---------------------------------------------------------------
Timing---------------------------------------------------------------

Key Statistics & Ratios

Market Cap88.33B
Enterprise Value88.73B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.92
Price / Book0.31
Revenue (TTM)96.48B
Gross Profit (TTM)34.61B
EBITDA-12.09B
Profit Margin-8.77%
Operating Margin-42.24%
Return on Equity-3.05%
Return on Assets-3.86%
Shares Outstanding13.76M
Shares Float5.40M
Beta0.32
Dividend Yield3.12%
Dividend Rate200.00
Payout Ratio0.00%

Dividends

20261×
200.00Mar 30, 2026
20241×
500.00Dec 27, 2024